Company / Operating Income
Enovis Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$1.1B
FY2025
5-year range
-$1.1B / -$62.8M
FY2021-FY2025
Trend
-44.9%
vs FY2024
Sector context
#155 of 156
Health Care
What the data says
Among 156 Health Care companies, Enovis is in the bottom 1% for operating income. Operating Income has fluctuated over the past 10 years, ranging from -$1.1B in FY2025 to $266M in FY2017.
Based on SEC 10-K filings.
-$1.1B in FY2025.
Declined from -$63M to -$1.1B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 156This company -$1.1B Sector average $733.1M
▼
-253.4% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 44.9% year-over-year.
- Ranks #155 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.1B | -44.9% |
| FY2024 | -$775.7M | -1135.2% |
| FY2023 | -$62.8M | +5.1% |
| FY2022 | -$66.2M | -5.4% |
| FY2021 | -$62.8M | -141.4% |
| FY2020 | $151.5M | +11.8% |
| FY2019 | $135.6M | -10.5% |
| FY2018 | $151.5M | -43.0% |
| FY2017 | $265.6M | +12.2% |
| FY2016 | $236.8M | -41.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026